Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2010 Jun;38(3):169-78.
doi: 10.1007/s00240-010-0262-9. Epub 2010 Mar 12.

Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects

Affiliations
Controlled Clinical Trial

Probiotic-induced reduction of gastrointestinal oxalate absorption in healthy subjects

Joseph Okombo et al. Urol Res. 2010 Jun.

Abstract

Both a high dietary oxalate intake and increased intestinal absorption appear to be major causes of elevated urine oxalate, a risk factor for kidney stone formation. By favorably altering the gastrointestinal bacterial population, probiotics have the potential to lower oxalate absorption/urinary excretion. This study assessed whether a 4-wk daily consumption of a commercially available probiotic by 11 healthy volunteers (8 females, 3 males), aged 21-36 y, would decrease oxalate absorption. The study involved the ingestion of a probiotic (VSL#3) for a 4 wk period followed by a 4 wk washout period. Oxalate load tests, providing a total of 80 mg oxalate, were conducted at baseline (pre-probiotic), and after the probiotic and washout periods. In the total subject population, mean total 22 h oxalate absorption at baseline (30.8 %) was significantly higher than after the probiotic (11.6 %) and washout (11.5 %) periods. However, four subjects identified as high oxalate absorbers at baseline had a particularly marked probiotic-induced reduction in oxalate absorption, which largely accounted for the reduction observed in the total subject population. The overall data suggested that in individuals characterized by high oxalate absorption levels, VSL#3 ingestion has the potential to reduce gastrointestinal oxalate absorption, which could decrease risk of kidney stones and other disorders related to hyperoxaluria.

PubMed Disclaimer

References

    1. Int J Urol. 1996 Jan;3(1):31-4 - PubMed
    1. Pflugers Arch. 1993 May;423(3-4):206-12 - PubMed
    1. J Am Soc Nephrol. 2008 Jun;19(6):1197-203 - PubMed
    1. J Am Soc Nephrol. 1994 Dec;5(6):1339-43 - PubMed
    1. Scanning Microsc. 1995;9(4):1109-18; discussion 1118-20 - PubMed

Publication types

LinkOut - more resources